By Jacob Gronholt-Pedersen and Patrick Wingrove COPENHAGEN, Nov 4 (Reuters) – Novo Nordisk's Wegovy weight-loss pill beat third-quarter sales forecasts and the drug maker lifted its full-year outlook
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)